Sudarshan Chemical Board Approves Audited Results, Recommends Final Dividend
Sudarshan Chemical Industries Limited's Board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. A final dividend of ₹5 per share (250%) was recommended, subject to shareholder approval. PricewaterhouseCoopers Services LLP and Mrs. Ashwini Kedar Joshi were appointed as Internal and Cost Auditors respectively for FY2026-27.
The approval of financial results and dividend recommendation are significant corporate actions that impact shareholder value and provide clarity on the company's performance. The appointment of auditors is a routine but important governance function.
The announcement includes the approval of audited financial results and the recommendation of a final dividend, which are generally positive for shareholders.
Sudarshan Chemical Industries Limited announced the outcome of its Board Meeting held on 25th May, 2026. The Board approved the Audited Financial Results, both standalone and consolidated, for the quarter and financial year ended 31st March, 2026. The Audit Committee had reviewed and recommended these results prior to the Board's approval.
Additionally, the Board recommended a Final Dividend of ₹5/- (250%) per equity share of face value ₹2/- each for the Financial Year 2025-26. This recommendation is subject to the approval of the company's members at the upcoming Annual General Meeting and is to be paid/dispatched within 30 days of its declaration.
The Board also approved the appointment of PricewaterhouseCoopers Services LLP as the Internal Auditor and Mrs. Ashwini Kedar Joshi as the Cost Auditor for the Financial Year 2026-27, based on the recommendations of the Audit Committee.
The trading window for dealing in the company's securities will reopen on Thursday, 28th May, 2026, 48 hours after the declaration of the audited financial results. The Board Meeting commenced at 3:30 p.m. (IST) and concluded at 6:30 p.m. (IST).
What to do with a filing like this
Sudarshan Chemical Industries Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Sudarshan Chemical Industries Limited. Read the original for the full detail.